No data to show
OTCM
GRCU
Market cap522kUSD
Jul 09, Last price
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-99.65%
IPO
-100.00%
Name
Green Cures & Botanical Distribution Inc
Chart & Performance
P/E
1.28
P/S
0.22
EPS
0.00
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
75.25%
Revenues
2m
+2,207.55%
Net income
409k
P
CFO
32k
P
Profile
Green Cures & Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. It focuses on the production, distribution, and management of cannabis-derived products. The company's products comprise nutritional supplements, vitamins, minerals, herbs/botanicals, sports nutrition, and specialty products. It also provides online community portals that supply public with information and resources regarding the benefits of cannabis-derived products. Green Cures & Botanical Distribution Inc. is based in Inglewood, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 2,356 2,207.55% | 102 -24.86% | |||||||
Cost of revenue | 967 | 27 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,389 | 75 | |||||||
NOPBT Margin | 58.97% | 73.08% | |||||||
Operating Taxes | 1 | (5) | |||||||
Tax Rate | 0.00% | ||||||||
NOPAT | 1,389 | 75 | |||||||
Net income | 409 -190.44% | (452) -13.19% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 416 | ||||||||
BB yield | -90.50% | ||||||||
| Debt | |||||||||
Debt current | 364 | 738 | |||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (277) | 304 | |||||||
| Cash flow | |||||||||
Cash from operating activities | 32 | (118) | |||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | 174 | 107 | |||||||
FCF | 1,308 | 29 | |||||||
| Balance | |||||||||
Cash | 206 | (365) | |||||||
Long term investments | 434 | 434 | |||||||
Excess cash | 523 | 429 | |||||||
Stockholders' equity | (1,258) | (1,839) | |||||||
Invested Capital | 2,357 | 2,379 | |||||||
ROIC | 58.66% | 3.52% | |||||||
ROCE | 128.11% | 13.82% | |||||||
| EV | |||||||||
Common stock shares outstanding | 4,597,733 | 1,710,838 | |||||||
Price | 0.00 -85.71% | 0.00 -58.82% | |||||||
Market cap | 460 -61.61% | 1,198 -54.22% | |||||||
EV | 188 | 1,506 | |||||||
EBITDA | 1,417 | 89 | |||||||
EV/EBITDA | 0.13 | 16.98 | |||||||
Interest | 46 | 22 | |||||||
Interest/NOPBT | 3.34% | 30.10% | |||||||